This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wüstenberg, T., Begemann, M., Bartels, C. et al. EPO treatment preserves gray matter in discrete brain regions of chronic schizophrenic patients: indication of areas with most progressive neurodegeneration inherent to the disease process. Mol Psychiatry 16, 1 (2011). https://doi.org/10.1038/mp.2010.126
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2010.126
This article is cited by
-
Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin
Nature Communications (2020)
-
Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain
Cellular and Molecular Life Sciences (2017)
-
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression
Psychopharmacology (2012)
-
Simultaneous genotyping of multiple polymorphisms in human serotonin transporter gene and detection of novel allelic variants
Translational Psychiatry (2011)
-
The Neurobiology of Erythropoietin
Cellular and Molecular Neurobiology (2011)